Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers

Cancer Letters

Volumn 267, Issue 1, 2008, Pages 55-66

  Huggins, Christopher Jack ^a   Andrulis, Irene L ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; DNA methylation; Focal adhesions; LIM domain containing gene 1 (LIMD1)

Indexed keywords

PROTEIN LIMD1; TUMOR SUPPRESSOR PROTEIN; VINCULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; EMBRYO; FOCAL ADHESION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOSIS; PHOSPHORYLATION; RNA;

EID: 45849120971     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.015     Document Type: Article

References (22)

1. Kiss H., Kedra D., Yang Y., Kost-Alimova M., Kiss C., O'Brien K.P., Fransson I., Klein G., Imreh S., and Dumanski J.P. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum. Genet. 105 (1999) 552-559
2. Hirota T., Kunitoku N., Sasayama T., Marumoto T., Zhang D., Nitta M., Hatakeyama K., and Saya H. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114 (2003) 585-598
3. Hirota T., Morisaki T., Nishiyama Y., Marumoto T., Tada K., Hara T., Masuko N., Inagaki M., Hatakeyama K., and Saya H. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J. Cell Biol. 149 (2000) 1073-1086
4. Sharp T.V., Munoz F., Bourboulia D., Presneau N., Darai E., Wang H.W., Cannon M., Butcher D.N., Nicholson A.G., Klein G., Imreh S., and Boshoff C. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc. Natl. Acad. Sci. USA 101 (2004) 16531-16536
5. Feng Y., Zhao H., Luderer H.F., Epple H., Ross F.P., Teitelbaum S.L., and Longmore G.D. The LIM protein, LIMD1, regulates AP-1 activation through an interaction with TRAF6 to influence osteoclast development. J. Biol. Chem. 282 (2007) 39-48
6. Lerman M.I., and Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60 (2000) 6116-6133
7. Miller B.J., Wang D., Krahe R., and Wright F.A. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am. J. Hum. Genet. 73 (2003) 748-767
8. Chakraborty S.B., Dasgupta S., Roy A., Sengupta A., Ray B., Roychoudhury S., and Panda C.K. Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients. Cancer Genet. Cytogenet. 146 (2003) 130-138
9. Huggins C.J., Gill M., and Andrulis I.L. Identification of rare variants in the hLIMD1 gene in breast cancer. Cancer Genet. Cytogenet. 178 (2007) 36-41
10. Andrulis I.L., Bull S.B., Blackstein M.E., Sutherland D., Mak C., Sidlofsky S., Pritzker K.P., Hartwick R.W., Hanna W., Lickley L., Wilkinson R., Qizilbash A., Ambus U., Lipa M., Weizel H., Katz A., Baida M., Mariz S., Stoik G., Dacamara P., Strongitharm D., Geddie W., and McCready D. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J. Clin. Oncol. 16 (1998) 1340-1349
11. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
12. Szabo A., Perou C.M., Karaca M., Perreard L., Quackenbush J.F., and Bernard P.S. Statistical modeling for selecting housekeeper genes. Genome Biol. 5 (2004) R59
13. Cukierman E., Pankov R., and Yamada K.M. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14 (2002) 633-639
14. Wehrle-Haller B., and Imhof B. The inner lives of focal adhesions. Trends Cell Biol. 12 (2002) 382-389
15. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 (2005) 597-610
16. Hsieh C.L., and Jones P.A. Meddling with methylation. Nat. Cell Biol. 5 (2003) 502-504
17. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
18. European Bioinformatics Institute.
19. Kadrmas J.L., and Beckerle M.C. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5 (2004) 920-931
20. Petit M.M., Crombez K.R., Vervenne H.B., Weyns N., and Van de Ven W.J. The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins. FEBS Lett. 579 (2005) 5061-5068
21. Rae J.M., Ramus S.J., Waltham M., Armes J.E., Campbell I.G., Clarke R., Barndt R.J., Johnson M.D., and Thompson E.W. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin. Exp. Metastasis 21 (2004) 543-552
22. Rae J.M., Creighton C.J., Meck J.M., Haddad B.R., and Johnson M.D. MDA-MB-435 cells are derived from M14 Melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 104 (2006) 13-19